{"news_desk": "Business", "print_page": null, "subsection_name": "DealBook", "section_name": "Business Day", "byline": {"original": "By ROBERT CYRAN", "person": [{"firstname": "Robert", "rank": 1, "lastname": "CYRAN", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "393", "keywords": [{"rank": "1", "value": "Antitrust Laws and Competition Issues", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Food and Drug Administration", "is_major": "N", "name": "organizations"}, {"rank": "3", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}], "lead_paragraph": "Prosecutors are investigating drug makers for colluding over prices, but higher consumer costs may be a natural consequence of reduced competition.", "pub_date": "2016-11-04T19:27:29Z", "document_type": "article", "source": "The New York Times", "snippet": "Prosecutors are investigating drug makers for colluding over prices, but higher consumer costs may be a natural consequence of reduced competition....", "multimedia": [], "web_url": "http://www.nytimes.com/2016/11/05/business/dealbook/competition-would-be-the-best-solution-to-rising-drug-prices.html", "slideshow_credits": null, "blog": [], "_id": "581ce12c7c459f6a5fccc51a", "headline": {"main": "Competition Would Be the Best Solution to Rising Drug Prices", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}}